NR3C2 and atherosclerosis: While experimental studies reported the reduction of atherosclerosis upon MR blockade [15], other clinical studies revealed that aldosterone infusion raised circulating IL-6 levels in contrast to spironolactone, which blocked IL-6 accompanied with administration of angiotensin II [16].